Mediar Therapeutics
Clinical trials sponsored by Mediar Therapeutics, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New antibody MTX-439 enters first human trial for diabetic kidney disease Results expected May 2027 (estimated)
- New antibody drug aims to slow lung scarring in IPF Results expected Aug 2027 (estimated)